Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Celldex Therapeutics (CLDX)

2.62 +0.04 (+1.55%)

6/23/2017  4:00pm

Open:

2.57

Pre. Close:

2.58

High:

2.64

Low:

2.50

Volume:

3,625,821

Market Cap:

327.77M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.68 - 2.74

2.74 - 2.78

Low:

2.37 - 2.43

2.43 - 2.47

Close:

2.53 - 2.65

2.65 - 2.73

Technical analysis  (as of: 2017-06-23 4:33:13 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 3.30     One year: 3.75

Support:

Support1: 2.20    Support2: 1.83

Resistance:

Resistance1: 2.82    Resistance2: 3.21

Pivot:

2.48

Moving Averages:

MA(5): 2.51     MA(20): 2.62

MA(100): 3.19     MA(250): 3.64

MACD:

MACD(12,26): -0.16     Signal(12,26,9): -0.19

%K %D:

%K(14,3): 47.30     %D(3): 36.28

RSI:

RSI(14): 46.38

52-Week:

High: 5.02  Low: 2.20  Change(%): -42.7

Average Vol(K):

3-Month: 102735  10-Days 2429

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CLDX has closed below upper band by 33.9%. Bollinger Bands are 65.5% wider than normal. The large width of the bands suggest high volatility as compared to CLDX's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Thu, 01 Jun 2017 13:30:00 GMT
Celldex Therapeutics, Inc.: The Bear Case from a Bull

Tue, 06 Jun 2017 20:48:45 GMT
Here's Why Celldex Therapeutics, Inc. Fell Today

Fri, 16 Jun 2017 12:00:00 GMT
Celldex Therapeutics Announces Additions to the Board of Directors and Senior ...

Mon, 05 Jun 2017 20:26:15 GMT
Celldex Therapeutics Presents Phase 1 Study of Varlilumab and Opdivo® at 2017 ...

Sat, 24 Jun 2017 02:15:00 GMT
ValuEngine Downgrades Celldex Therapeutics, Inc. (CLDX) to Strong Sell

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

125.11

Shares Float (M)

117.67

% Held by Insiders

0.54

% Held by Institutions

89.20

Shares Short (K)

19290

Shares Short Prior Month (K)

17880

Stock Financials

EPS

-1.190

EPS Est. Current Year

-1.110

EPS Est. Next Year

-1.030

EPS Est. Next Quarter

-0.280

Forward EPS

-1.028

Book Value (p.s.)

2.000

PEG Ratio

Profit Margin

Operating Margin

-1773.41

Return on Assets (ttm)

-23.5

Return on Equity (ttm)

-50.5

Qtrly Rev. Growth

17.7

Gross Profit (p.s.)

0.054

Sales Per Share

EBITDA (p.s.)

-0.957

Qtrly Earnings Growth

Operating Cash Flow (M)

-113.40

Levered Free Cash Flow (M)

-58.54

FoxReading.com

Valuation

P/E

-2.20

P/E Growth Ratio

0.02

P/BV

1.31

P/S

5463136256.00

P/CF

-2.89

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

0.083

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.